The global demand for Personalized Medicine Biomarkers Market is presumed to reach the market size of nearly USD 175.46 BN by 2030 from USD 24.92 BN in 2022 with a CAGR of 27.63% under the study period 2023 - 2030.
Personalised medicine biomarkers are the use of biomarkers for developing personalised medicines for patients. It assists in making treatment decisions, improving treatment outcomes and creating safe therapies for patients. It also helps predict the occurrence of health issues and dose selection due to their prognostic utility. Biomarker helps in the early detection of diseases, increase the chance of patient survival, and reduce treatment cost.
The personalised medicine biomarkers market growth is witnessing an upward trend due to the rising prevalence of chronic diseases all over the globe. The advancement in diagnosis and detection of chronic diseases, coupled with the growing demand for personalised medicines, are contributing to the growth of this market. Increasing awareness regarding the importance of predicting prognosis is surging the demand for the personalised medicine biomarkers market. In addition, different advantages of personalised medicine biomarkers, such as early detection of diseases and reduction in the cost of treatment, are propelling the demand for this market. Furthermore, continuous advancement in the development of biomarkers is expected to boost the growth of personalised medicine biomarkers in the market over the forecast period.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of personalized medicine biomarkers. The growth and trends of personalized medicine biomarkers industry provide a holistic approach to this study.
This section of the personalized medicine biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Application
By Indication
This section covers the regional outlook, which accentuates current and future demand for the Personalized Medicine Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the personalized medicine biomarkers market include Laboratory Corporation of America Holding, Quest Diagnostics Incorporated, Agilent Technologies Inc., Genome Medical Inc., Coriell Life Sciences., Thermo Fisher Scientific Inc., NeoGenomics Laboratories, Foundation Medicine Inc, Illumina Inc., Guardant Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: